RA_Map Consortium also identified three DAS28-CRP trajectory classes in 267 untreated RA patients from 18 UK centres; 21.7% as inadequate responders, 21.3% as higher baseline activity and 57% as lower baseline activity (moderate status at baseline) both with sustained improvement over 18 months. The gene discussed is CRP; the disease is rheumatoid arthritis.